Status:
COMPLETED
Finnish Registry of Transcatheter and Surgical Aortic Valve Replacement for Aortic Valve Stenosis: FinnValve Registry
Lead Sponsor:
Turku University Hospital
Collaborating Sponsors:
Helsinki University Central Hospital
Oulu University Hospital
Conditions:
Aortic Valve Stenosis
Eligibility:
All Genders
18+ years
Brief Summary
The FinnValve investigators planned a nationwide registry to investigate the early and late outcome of transcatheter aortic valve implantation (TAVI) compared to surgical aortic valve replacement (SAV...
Detailed Description
Rationale of the study Uncertainty regarding the potential benefits of transcatheter aortic valve implantation (TAVI) compared to surgical aortic valve replacement (SAVR) in patients with aortic valve...
Eligibility Criteria
Inclusion
- Patients who underwent transcatheter (TAVI) or surgical aortic valve replacement (SAVR) for severe aortic valve stenosis
- Patients aged \>18 years
- Primary aortic valve procedure with a bioprosthesis for AS with or without associated regurgitation.
- TAVI and SAVR with or without associated coronary revascularization
- TAVI and SAVR for AS after any prior major cardiac surgery with exception of any maze procedure and/or closure of the left atrial appendage.
Exclusion
- Patients who underwent any prior SAVR or TAVI
- Patients undergoing concomitant procedures on the mitral valve, tricuspid valve or the ascending aorta.
- Patients operated on for aortic valve endocarditis
- Patients operated for isolated aortic valve regurgitation.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 9 2020
Estimated Enrollment :
6463 Patients enrolled
Trial Details
Trial ID
NCT03385915
Start Date
December 1 2017
End Date
March 9 2020
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heart Center, Turku University Hospital
Turku, Finland, 20521